

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.69333399 |
| 2 | viral transcription (GO:0019083) | 5.53799746 |
| 3 | translational termination (GO:0006415) | 5.35304409 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.27816623 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 5.27816623 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.98717903 |
| 7 | translational elongation (GO:0006414) | 4.90791842 |
| 8 | protein retention in ER lumen (GO:0006621) | 4.73973933 |
| 9 | translational initiation (GO:0006413) | 4.59320487 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.56380212 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.49657780 |
| 12 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.40980503 |
| 13 | nuclear envelope reassembly (GO:0031468) | 4.35988412 |
| 14 | mitotic nuclear envelope reassembly (GO:0007084) | 4.35988412 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.33575423 |
| 16 | viral life cycle (GO:0019058) | 4.31950143 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.30734746 |
| 18 | regulation of early endosome to late endosome transport (GO:2000641) | 4.24778836 |
| 19 | protein targeting to ER (GO:0045047) | 4.21306039 |
| 20 | cellular protein complex disassembly (GO:0043624) | 4.20446913 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 4.16365969 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.15265162 |
| 23 | maturation of SSU-rRNA (GO:0030490) | 4.14468404 |
| 24 | establishment of viral latency (GO:0019043) | 4.10120697 |
| 25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.00183064 |
| 26 | establishment of integrated proviral latency (GO:0075713) | 3.99774054 |
| 27 | regulation of protein heterodimerization activity (GO:0043497) | 3.97378933 |
| 28 | protein localization to endosome (GO:0036010) | 3.95778308 |
| 29 | protein localization to endoplasmic reticulum (GO:0070972) | 3.93291248 |
| 30 | ribosomal large subunit biogenesis (GO:0042273) | 3.89586986 |
| 31 | regulation of translational termination (GO:0006449) | 3.85041992 |
| 32 | protein complex disassembly (GO:0043241) | 3.79224078 |
| 33 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.69681950 |
| 34 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.69245253 |
| 35 | DNA deamination (GO:0045006) | 3.63791120 |
| 36 | macromolecular complex disassembly (GO:0032984) | 3.60008265 |
| 37 | DNA unwinding involved in DNA replication (GO:0006268) | 3.45365269 |
| 38 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.45234969 |
| 39 | ribosome assembly (GO:0042255) | 3.44282862 |
| 40 | maternal placenta development (GO:0001893) | 3.28727365 |
| 41 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.28124596 |
| 42 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.26925757 |
| 43 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.21717559 |
| 44 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.18130496 |
| 45 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.14868264 |
| 46 | cellular copper ion homeostasis (GO:0006878) | 3.13826094 |
| 47 | UV protection (GO:0009650) | 3.12549644 |
| 48 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.09104622 |
| 49 | translation (GO:0006412) | 3.08371735 |
| 50 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.06837005 |
| 51 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.06837005 |
| 52 | pentose-phosphate shunt (GO:0006098) | 3.06713279 |
| 53 | actin nucleation (GO:0045010) | 3.05742183 |
| 54 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.03828514 |
| 55 | protein targeting to membrane (GO:0006612) | 3.02336645 |
| 56 | T cell apoptotic process (GO:0070231) | 3.01305950 |
| 57 | glycosphingolipid catabolic process (GO:0046479) | 2.99985133 |
| 58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99963171 |
| 59 | regulation of translational fidelity (GO:0006450) | 2.99500383 |
| 60 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.93731066 |
| 61 | pinocytosis (GO:0006907) | 2.93586461 |
| 62 | barbed-end actin filament capping (GO:0051016) | 2.90259315 |
| 63 | DNA strand elongation (GO:0022616) | 2.89278038 |
| 64 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.88958566 |
| 65 | glucose catabolic process (GO:0006007) | 2.87814551 |
| 66 | ncRNA 3-end processing (GO:0043628) | 2.86177228 |
| 67 | ribosome biogenesis (GO:0042254) | 2.86175322 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 2.85058186 |
| 69 | apoptotic cell clearance (GO:0043277) | 2.83564933 |
| 70 | proline biosynthetic process (GO:0006561) | 2.82650627 |
| 71 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.81030587 |
| 72 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.80943323 |
| 73 | skin morphogenesis (GO:0043589) | 2.79317289 |
| 74 | histone arginine methylation (GO:0034969) | 2.78809813 |
| 75 | positive regulation of lamellipodium assembly (GO:0010592) | 2.78597722 |
| 76 | heterochromatin organization (GO:0070828) | 2.76173591 |
| 77 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.75536760 |
| 78 | mRNA catabolic process (GO:0006402) | 2.73991909 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.72797283 |
| 80 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.72531293 |
| 81 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.72223109 |
| 82 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70872655 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70711747 |
| 84 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.70111175 |
| 85 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.70080590 |
| 86 | folic acid metabolic process (GO:0046655) | 2.69464381 |
| 87 | RNA catabolic process (GO:0006401) | 2.69172165 |
| 88 | DNA replication initiation (GO:0006270) | 2.69081411 |
| 89 | peptidyl-proline hydroxylation (GO:0019511) | 2.68910932 |
| 90 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.67414609 |
| 91 | NADPH regeneration (GO:0006740) | 2.66947955 |
| 92 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.66551829 |
| 93 | regulation of gene silencing by miRNA (GO:0060964) | 2.66551829 |
| 94 | regulation of gene silencing by RNA (GO:0060966) | 2.66551829 |
| 95 | adhesion of symbiont to host cell (GO:0044650) | 2.65569555 |
| 96 | virion attachment to host cell (GO:0019062) | 2.65569555 |
| 97 | pentose metabolic process (GO:0019321) | 2.65252354 |
| 98 | protein localization to kinetochore (GO:0034501) | 2.65100133 |
| 99 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.64751286 |
| 100 | nucleobase biosynthetic process (GO:0046112) | 2.64718051 |
| 101 | cellular response to arsenic-containing substance (GO:0071243) | 2.64248452 |
| 102 | cyclooxygenase pathway (GO:0019371) | 2.63706773 |
| 103 | mitochondrial fusion (GO:0008053) | 2.63660371 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62547018 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 2.62547018 |
| 106 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62547018 |
| 107 | modulation by symbiont of host defense response (GO:0052031) | 2.62547018 |
| 108 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62547018 |
| 109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62547018 |
| 110 | hyaluronan catabolic process (GO:0030214) | 2.62013085 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.60760034 |
| 112 | protein insertion into membrane (GO:0051205) | 2.60474880 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58466913 |
| 114 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.55868379 |
| 115 | adhesion of symbiont to host (GO:0044406) | 2.55760174 |
| 116 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.55606304 |
| 117 | lymphocyte apoptotic process (GO:0070227) | 2.55371702 |
| 118 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.55294578 |
| 119 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.54668772 |
| 120 | cell adhesion mediated by integrin (GO:0033627) | 2.54567866 |
| 121 | regulation of superoxide anion generation (GO:0032928) | 2.53386190 |
| 122 | purine nucleobase biosynthetic process (GO:0009113) | 2.52474657 |
| 123 | de novo protein folding (GO:0006458) | 2.52451743 |
| 124 | interferon-gamma secretion (GO:0072643) | 2.52214279 |
| 125 | sequestering of actin monomers (GO:0042989) | 2.51062887 |
| 126 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.50759514 |
| 127 | immunoglobulin mediated immune response (GO:0016064) | 2.50676167 |
| 128 | amino sugar catabolic process (GO:0046348) | 2.50316284 |
| 129 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49603781 |
| 130 | negative regulation of ligase activity (GO:0051352) | 2.49603781 |
| 131 | epithelial cell-cell adhesion (GO:0090136) | 2.49365975 |
| 132 | rRNA processing (GO:0006364) | 2.49363452 |
| 133 | embryo implantation (GO:0007566) | 2.48453674 |
| 134 | glucose 6-phosphate metabolic process (GO:0051156) | 2.48125291 |
| 135 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47457551 |
| 136 | negative regulation of cell size (GO:0045792) | 2.46506042 |
| 137 | prostanoid biosynthetic process (GO:0046457) | 2.46479732 |
| 138 | prostaglandin biosynthetic process (GO:0001516) | 2.46479732 |
| 139 | extracellular fibril organization (GO:0043206) | 2.46457614 |
| 140 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.45763425 |
| 141 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.45763425 |
| 142 | negative regulation of RNA splicing (GO:0033119) | 2.45731135 |
| 143 | morphogenesis of an endothelium (GO:0003159) | 2.45565821 |
| 144 | endothelial tube morphogenesis (GO:0061154) | 2.45565821 |
| 145 | protein hydroxylation (GO:0018126) | 2.45471422 |
| 146 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.45175149 |
| 147 | mitotic nuclear envelope disassembly (GO:0007077) | 2.43047995 |
| 148 | B cell mediated immunity (GO:0019724) | 2.42211577 |
| 149 | positive regulation of lamellipodium organization (GO:1902745) | 2.41859717 |
| 150 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.41851061 |
| 151 | mitochondrial calcium ion transport (GO:0006851) | 2.41815128 |
| 152 | glial cell migration (GO:0008347) | 2.41460406 |
| 153 | virion assembly (GO:0019068) | 2.37982232 |
| 154 | de novo posttranslational protein folding (GO:0051084) | 2.37379377 |
| 155 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.37186291 |
| 156 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.36891447 |
| 157 | rRNA metabolic process (GO:0016072) | 2.36886836 |
| 158 | spliceosomal snRNP assembly (GO:0000387) | 2.36542940 |
| 159 | negative regulation of mitochondrion organization (GO:0010823) | 2.36516454 |
| 160 | peptidyl-arginine methylation (GO:0018216) | 2.36395128 |
| 161 | peptidyl-arginine N-methylation (GO:0035246) | 2.36395128 |
| 162 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.35351347 |
| 163 | oligosaccharide catabolic process (GO:0009313) | 2.34968809 |
| 164 | mitotic chromosome condensation (GO:0007076) | 2.32647872 |
| 165 | pyrimidine-containing compound salvage (GO:0008655) | 2.32438530 |
| 166 | pyrimidine nucleoside salvage (GO:0043097) | 2.32438530 |
| 167 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.32293493 |
| 168 | endodermal cell differentiation (GO:0035987) | 2.32280838 |
| 169 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.31716297 |
| 170 | transferrin transport (GO:0033572) | 2.31602156 |
| 171 | stress fiber assembly (GO:0043149) | 2.30311063 |
| 172 | protein complex localization (GO:0031503) | 2.29370312 |
| 173 | basement membrane organization (GO:0071711) | 2.29039911 |
| 174 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.27654107 |
| 175 | natural killer cell mediated immunity (GO:0002228) | 2.27654107 |
| 176 | ceramide catabolic process (GO:0046514) | 2.26362122 |
| 177 | activation of MAPKKK activity (GO:0000185) | 2.24756523 |
| 178 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.21234187 |
| 179 | polyamine biosynthetic process (GO:0006596) | 2.21015496 |
| 180 | positive regulation of nuclease activity (GO:0032075) | 2.20644628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.49282633 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04052838 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.36187118 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17808741 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.57715450 |
| 6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.56082586 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55137140 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.46847959 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.17205984 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14725216 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14182775 |
| 12 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.12978309 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.10690361 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.06411530 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02364070 |
| 16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.96574230 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80512944 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79733664 |
| 19 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78361426 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77519794 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72189299 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.71384632 |
| 23 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69592782 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69288414 |
| 25 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.68786854 |
| 26 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.67601652 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65902655 |
| 28 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64219871 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63541196 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59005527 |
| 31 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58683005 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.58253688 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56676843 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55544139 |
| 35 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.55194226 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53811215 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48880245 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48548109 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48199482 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46871916 |
| 41 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46439968 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46127250 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45399175 |
| 44 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.44216608 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43061681 |
| 46 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.41409272 |
| 47 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39412166 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39002396 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.37866814 |
| 50 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.36768413 |
| 51 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.35293123 |
| 52 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.34306074 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34155741 |
| 54 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33610946 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.31979560 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31850835 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31788223 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31509908 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30454341 |
| 60 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30058965 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29712013 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28708890 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28680342 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27915952 |
| 65 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.26968991 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26677429 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26087209 |
| 68 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24776527 |
| 69 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24149331 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22785228 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22725679 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22463915 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21362188 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21329326 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21321830 |
| 76 | * P68_20966046_ChIP-Seq_HELA_Human | 1.21221906 |
| 77 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21077914 |
| 78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.21038484 |
| 79 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.19784482 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19513468 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19439975 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.19263576 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19061036 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18414115 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17675224 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16409369 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16240185 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15511402 |
| 89 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.15487868 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15355429 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14930483 |
| 92 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14614508 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14574185 |
| 94 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.14498739 |
| 95 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14026401 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13965697 |
| 97 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.13726485 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13675245 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12018946 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11656668 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11621337 |
| 102 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11381814 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10688543 |
| 104 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.10446653 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09084797 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09035750 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08899809 |
| 108 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08899475 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08760937 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08725514 |
| 111 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08259451 |
| 112 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07063569 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06931238 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05372588 |
| 115 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.05182262 |
| 116 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05032143 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04409967 |
| 118 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.04118886 |
| 119 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04077606 |
| 120 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03418002 |
| 121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02934833 |
| 122 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00596740 |
| 123 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00251998 |
| 124 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00058472 |
| 125 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00055281 |
| 126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99045915 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.98198859 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98187386 |
| 129 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97829445 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97235368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.37046409 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.84437409 |
| 3 | MP0003303_peritoneal_inflammation | 3.57534524 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.48419643 |
| 5 | MP0009840_abnormal_foam_cell | 3.25886389 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.21968128 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.18721304 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.92997936 |
| 9 | MP0005451_abnormal_body_composition | 2.70620686 |
| 10 | MP0008260_abnormal_autophagy | 2.60946119 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.56100811 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.44517641 |
| 13 | MP0003329_amyloid_beta_deposits | 2.44083742 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.37340925 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.36208530 |
| 16 | MP0003436_decreased_susceptibility_to | 2.34420868 |
| 17 | MP0004272_abnormal_basement_membrane | 2.32640327 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.26868970 |
| 19 | MP0010307_abnormal_tumor_latency | 2.24702621 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.23492753 |
| 21 | MP0003566_abnormal_cell_adhesion | 2.16861736 |
| 22 | MP0003186_abnormal_redox_activity | 2.12974221 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.12376739 |
| 24 | MP0003077_abnormal_cell_cycle | 2.10672418 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.99131140 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.88319991 |
| 27 | MP0000858_altered_metastatic_potential | 1.82166558 |
| 28 | MP0001730_embryonic_growth_arrest | 1.80446558 |
| 29 | MP0001542_abnormal_bone_strength | 1.77750952 |
| 30 | MP0000490_abnormal_crypts_of | 1.72594569 |
| 31 | MP0005501_abnormal_skin_physiology | 1.71329698 |
| 32 | MP0003123_paternal_imprinting | 1.69729541 |
| 33 | MP0005023_abnormal_wound_healing | 1.67274712 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.65897540 |
| 35 | MP0008007_abnormal_cellular_replicative | 1.59208405 |
| 36 | MP0001849_ear_inflammation | 1.58656146 |
| 37 | MP0000350_abnormal_cell_proliferation | 1.58506815 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.58121709 |
| 39 | MP0009278_abnormal_bone_marrow | 1.57650024 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.53895515 |
| 41 | MP0005165_increased_susceptibility_to | 1.53569061 |
| 42 | MP0006082_CNS_inflammation | 1.47014913 |
| 43 | MP0004233_abnormal_muscle_weight | 1.46510320 |
| 44 | MP0008932_abnormal_embryonic_tissue | 1.42252252 |
| 45 | MP0003448_altered_tumor_morphology | 1.41851572 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.41338494 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.36399644 |
| 48 | MP0001243_abnormal_dermal_layer | 1.35925316 |
| 49 | MP0002796_impaired_skin_barrier | 1.33078619 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.32185808 |
| 51 | MP0004858_abnormal_nervous_system | 1.31748226 |
| 52 | MP0003634_abnormal_glial_cell | 1.31254278 |
| 53 | MP0010094_abnormal_chromosome_stability | 1.31142016 |
| 54 | MP0000358_abnormal_cell_content/ | 1.30152263 |
| 55 | MP0002080_prenatal_lethality | 1.29846885 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.28300759 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.28300759 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.27082140 |
| 59 | MP0003941_abnormal_skin_development | 1.26678350 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.24965113 |
| 61 | MP0001697_abnormal_embryo_size | 1.24005169 |
| 62 | MP0000537_abnormal_urethra_morphology | 1.23726848 |
| 63 | MP0002060_abnormal_skin_morphology | 1.22291488 |
| 64 | MP0002419_abnormal_innate_immunity | 1.21500987 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.21207652 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.19507265 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.18968293 |
| 68 | MP0006054_spinal_hemorrhage | 1.18664454 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.16864558 |
| 70 | MP0000685_abnormal_immune_system | 1.16749954 |
| 71 | MP0002396_abnormal_hematopoietic_system | 1.16376456 |
| 72 | MP0002722_abnormal_immune_system | 1.13767074 |
| 73 | MP0002086_abnormal_extraembryonic_tissu | 1.13672780 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.13143126 |
| 75 | MP0005197_abnormal_uvea_morphology | 1.11818710 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.10890641 |
| 77 | MP0000313_abnormal_cell_death | 1.08958993 |
| 78 | MP0002398_abnormal_bone_marrow | 1.08826424 |
| 79 | MP0001819_abnormal_immune_cell | 1.07657709 |
| 80 | MP0002405_respiratory_system_inflammati | 1.07514898 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.06840359 |
| 82 | MP0009053_abnormal_anal_canal | 1.04913607 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.04274843 |
| 84 | MP0003075_altered_response_to | 1.02407221 |
| 85 | MP0000604_amyloidosis | 1.01708235 |
| 86 | MP0001958_emphysema | 1.00991369 |
| 87 | MP0003283_abnormal_digestive_organ | 1.00546459 |
| 88 | MP0002429_abnormal_blood_cell | 1.00513715 |
| 89 | MP0003091_abnormal_cell_migration | 1.00491284 |
| 90 | MP0005025_abnormal_response_to | 1.00145408 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99390893 |
| 92 | MP0001800_abnormal_humoral_immune | 0.99319485 |
| 93 | MP0002084_abnormal_developmental_patter | 0.99133051 |
| 94 | MP0008770_decreased_survivor_rate | 0.98280988 |
| 95 | MP0000716_abnormal_immune_system | 0.96906908 |
| 96 | MP0001672_abnormal_embryogenesis/_devel | 0.96903908 |
| 97 | MP0005380_embryogenesis_phenotype | 0.96903908 |
| 98 | MP0000343_altered_response_to | 0.96622601 |
| 99 | MP0000747_muscle_weakness | 0.96384443 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.95729354 |
| 101 | MP0004947_skin_inflammation | 0.95429871 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.95065849 |
| 103 | MP0002723_abnormal_immune_serum | 0.95059966 |
| 104 | MP0001853_heart_inflammation | 0.94525943 |
| 105 | MP0005621_abnormal_cell_physiology | 0.92362868 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.92319040 |
| 107 | MP0004197_abnormal_fetal_growth/weight/ | 0.91737813 |
| 108 | MP0005193_abnormal_anterior_eye | 0.91733614 |
| 109 | MP0001915_intracranial_hemorrhage | 0.91354521 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.91339811 |
| 111 | MP0003984_embryonic_growth_retardation | 0.90633648 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.89748010 |
| 113 | MP0003315_abnormal_perineum_morphology | 0.89387158 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.88011931 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.87561740 |
| 116 | MP0005384_cellular_phenotype | 0.87560496 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.87395233 |
| 118 | MP0000762_abnormal_tongue_morphology | 0.85786488 |
| 119 | MP0000733_abnormal_muscle_development | 0.85636581 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.84915045 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.84337388 |
| 122 | MP0001881_abnormal_mammary_gland | 0.84323203 |
| 123 | MP0005166_decreased_susceptibility_to | 0.83855460 |
| 124 | MP0003119_abnormal_digestive_system | 0.83636743 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.83493349 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.82564472 |
| 127 | MP0002254_reproductive_system_inflammat | 0.81668186 |
| 128 | MP0010771_integument_phenotype | 0.80735803 |
| 129 | MP0001348_abnormal_lacrimal_gland | 0.80083640 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.79386364 |
| 131 | MP0005275_abnormal_skin_tensile | 0.79292527 |
| 132 | MP0004510_myositis | 0.78105218 |
| 133 | MP0000678_abnormal_parathyroid_gland | 0.77696919 |
| 134 | MP0000462_abnormal_digestive_system | 0.75846880 |
| 135 | MP0003279_aneurysm | 0.75703809 |
| 136 | MP0004859_abnormal_synaptic_plasticity | 0.75529119 |
| 137 | MP0000750_abnormal_muscle_regeneration | 0.74898351 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.74473331 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.72376865 |
| 140 | MP0004883_abnormal_blood_vessel | 0.70981710 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.70976143 |
| 142 | MP0003385_abnormal_body_wall | 0.69641530 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.67880118 |
| 144 | MP0000003_abnormal_adipose_tissue | 0.66152910 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.62147823 |
| 146 | MP0002092_abnormal_eye_morphology | 0.61618132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.80689348 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 3.67124773 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.29670428 |
| 4 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.27791680 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.25971335 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.24866689 |
| 7 | Nuclear cataract (HP:0100018) | 3.19299165 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.17161245 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.14591963 |
| 10 | Short nail (HP:0001799) | 3.11993167 |
| 11 | Multiple enchondromatosis (HP:0005701) | 3.01852978 |
| 12 | Diminished motivation (HP:0000745) | 2.99702371 |
| 13 | Insomnia (HP:0100785) | 2.96483568 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.92403109 |
| 15 | Reticulocytopenia (HP:0001896) | 2.92384219 |
| 16 | Agnosia (HP:0010524) | 2.91503597 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 2.90163982 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 2.86343235 |
| 19 | Trismus (HP:0000211) | 2.82346950 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81017230 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81017230 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81017230 |
| 23 | Hand muscle atrophy (HP:0009130) | 2.79435109 |
| 24 | Cervical subluxation (HP:0003308) | 2.77335462 |
| 25 | Personality changes (HP:0000751) | 2.76763172 |
| 26 | Apathy (HP:0000741) | 2.70202913 |
| 27 | Spinal muscular atrophy (HP:0007269) | 2.63277104 |
| 28 | Achilles tendon contracture (HP:0001771) | 2.63127985 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.61599269 |
| 30 | Genu recurvatum (HP:0002816) | 2.61578221 |
| 31 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.61563515 |
| 32 | Upper motor neuron abnormality (HP:0002127) | 2.61266496 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.60767160 |
| 34 | Disinhibition (HP:0000734) | 2.58489594 |
| 35 | Mucopolysacchariduria (HP:0008155) | 2.58293641 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58293641 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.56595265 |
| 38 | Abnormality of dentin (HP:0010299) | 2.56319411 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.55289334 |
| 40 | Abnormality of the anterior horn cell (HP:0006802) | 2.55289334 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.49572117 |
| 42 | Abnormality of the motor neurons (HP:0002450) | 2.48778054 |
| 43 | Abnormal neuron morphology (HP:0012757) | 2.48778054 |
| 44 | Microretrognathia (HP:0000308) | 2.48283162 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.46098048 |
| 46 | Overriding aorta (HP:0002623) | 2.40819018 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.39623834 |
| 48 | Upper limb muscle weakness (HP:0003484) | 2.35808783 |
| 49 | Pallor (HP:0000980) | 2.34821597 |
| 50 | Tetraparesis (HP:0002273) | 2.34518332 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34000683 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.34000683 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.33859348 |
| 54 | Upper limb amyotrophy (HP:0009129) | 2.33476260 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.33476260 |
| 56 | Premature rupture of membranes (HP:0001788) | 2.31962932 |
| 57 | Abnormality of the Achilles tendon (HP:0005109) | 2.30709697 |
| 58 | Thrombocytosis (HP:0001894) | 2.30389115 |
| 59 | Hyperparathyroidism (HP:0000843) | 2.29222435 |
| 60 | Macrocytic anemia (HP:0001972) | 2.28722580 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.28266953 |
| 62 | Selective tooth agenesis (HP:0001592) | 2.28263409 |
| 63 | Broad distal phalanx of finger (HP:0009836) | 2.27735501 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27527526 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27527526 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27527526 |
| 67 | Atrophic scars (HP:0001075) | 2.24636272 |
| 68 | Angiofibromas (HP:0010615) | 2.22302469 |
| 69 | Adenoma sebaceum (HP:0009720) | 2.22302469 |
| 70 | Cellulitis (HP:0100658) | 2.21793385 |
| 71 | Elbow flexion contracture (HP:0002987) | 2.21574850 |
| 72 | Fragile skin (HP:0001030) | 2.20940851 |
| 73 | Natal tooth (HP:0000695) | 2.20689218 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.19388656 |
| 75 | Poor head control (HP:0002421) | 2.19200651 |
| 76 | Axonal loss (HP:0003447) | 2.18893127 |
| 77 | Bladder diverticulum (HP:0000015) | 2.17980309 |
| 78 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17015783 |
| 79 | Entropion (HP:0000621) | 2.16529172 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.16263844 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.15700914 |
| 82 | Prolonged neonatal jaundice (HP:0006579) | 2.15127737 |
| 83 | Distal lower limb amyotrophy (HP:0008944) | 2.13270543 |
| 84 | Ragged-red muscle fibers (HP:0003200) | 2.11953623 |
| 85 | Spinal rigidity (HP:0003306) | 2.08996389 |
| 86 | Ankle contracture (HP:0006466) | 2.08184252 |
| 87 | Distal lower limb muscle weakness (HP:0009053) | 2.08147640 |
| 88 | Shallow orbits (HP:0000586) | 2.07924406 |
| 89 | Hypokinesia (HP:0002375) | 2.05492919 |
| 90 | Slender long bone (HP:0003100) | 2.03021737 |
| 91 | Limb-girdle muscle atrophy (HP:0003797) | 2.02726496 |
| 92 | Peritonitis (HP:0002586) | 2.02237760 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.02088561 |
| 94 | Renal duplication (HP:0000075) | 2.00256504 |
| 95 | Hyperacusis (HP:0010780) | 2.00217918 |
| 96 | Back pain (HP:0003418) | 1.99615885 |
| 97 | Fasciculations (HP:0002380) | 1.98387408 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 1.98374633 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96760317 |
| 100 | Elfin facies (HP:0004428) | 1.96480366 |
| 101 | Abnormal trabecular bone morphology (HP:0100671) | 1.94265404 |
| 102 | Cortical dysplasia (HP:0002539) | 1.92453375 |
| 103 | Spinal cord compression (HP:0002176) | 1.91763982 |
| 104 | Abnormality of the lower motor neuron (HP:0002366) | 1.89744496 |
| 105 | Global brain atrophy (HP:0002283) | 1.89643419 |
| 106 | Mutism (HP:0002300) | 1.89140062 |
| 107 | Hematochezia (HP:0002573) | 1.88623985 |
| 108 | Colon cancer (HP:0003003) | 1.88547176 |
| 109 | Spastic diplegia (HP:0001264) | 1.88408206 |
| 110 | Pelvic girdle muscle weakness (HP:0003749) | 1.87254379 |
| 111 | Shoulder girdle muscle weakness (HP:0003547) | 1.86875379 |
| 112 | Dilatation of the ascending aorta (HP:0005111) | 1.85700832 |
| 113 | Ulnar bowing (HP:0003031) | 1.84465790 |
| 114 | Ependymoma (HP:0002888) | 1.83934237 |
| 115 | Abnormal gallbladder physiology (HP:0012438) | 1.83633231 |
| 116 | Cholecystitis (HP:0001082) | 1.83633231 |
| 117 | Increased density of long bones (HP:0006392) | 1.82697578 |
| 118 | Rough bone trabeculation (HP:0100670) | 1.82214293 |
| 119 | Wormian bones (HP:0002645) | 1.81760937 |
| 120 | Hypercortisolism (HP:0001578) | 1.80343892 |
| 121 | Multiple lipomas (HP:0001012) | 1.77542134 |
| 122 | Mesangial abnormality (HP:0001966) | 1.76355093 |
| 123 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.75589587 |
| 124 | Pustule (HP:0200039) | 1.75105611 |
| 125 | Zonular cataract (HP:0010920) | 1.74808479 |
| 126 | Carpal bone hypoplasia (HP:0001498) | 1.74643522 |
| 127 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71564751 |
| 128 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71564751 |
| 129 | Basal cell carcinoma (HP:0002671) | 1.70156506 |
| 130 | Basal ganglia calcification (HP:0002135) | 1.69771919 |
| 131 | Lower limb amyotrophy (HP:0007210) | 1.69496051 |
| 132 | Abnormality of the umbilical cord (HP:0010881) | 1.68969931 |
| 133 | Amyloidosis (HP:0011034) | 1.68914601 |
| 134 | Bicuspid aortic valve (HP:0001647) | 1.68552167 |
| 135 | Joint stiffness (HP:0001387) | 1.68494743 |
| 136 | Hypercalcemia (HP:0003072) | 1.68347818 |
| 137 | Severe short stature (HP:0003510) | 1.67668371 |
| 138 | Blue sclerae (HP:0000592) | 1.67448766 |
| 139 | Petechiae (HP:0000967) | 1.66875379 |
| 140 | Neoplasm of the pancreas (HP:0002894) | 1.65254726 |
| 141 | Hepatosplenomegaly (HP:0001433) | 1.65250668 |
| 142 | Glossoptosis (HP:0000162) | 1.64767538 |
| 143 | Increased connective tissue (HP:0009025) | 1.64544173 |
| 144 | Enlarged penis (HP:0000040) | 1.64467168 |
| 145 | Radial bowing (HP:0002986) | 1.63839143 |
| 146 | Glomerulonephritis (HP:0000099) | 1.63474223 |
| 147 | Neoplasm of head and neck (HP:0012288) | 1.63432957 |
| 148 | Abnormality of reticulocytes (HP:0004312) | 1.62569851 |
| 149 | Autoimmune thrombocytopenia (HP:0001973) | 1.60692954 |
| 150 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.58872440 |
| 151 | Gastrointestinal carcinoma (HP:0002672) | 1.58872440 |
| 152 | Loss of speech (HP:0002371) | 1.58503007 |
| 153 | Cutaneous melanoma (HP:0012056) | 1.57808084 |
| 154 | Increased serum ferritin (HP:0003281) | 1.55331640 |
| 155 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.55115491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 3.35029200 |
| 2 | TRIB3 | 3.30177186 |
| 3 | NME2 | 3.13915889 |
| 4 | PKN2 | 2.96991511 |
| 5 | BUB1 | 2.87221129 |
| 6 | IRAK3 | 2.85246719 |
| 7 | PBK | 2.69230499 |
| 8 | MAP3K10 | 2.62074382 |
| 9 | ERN1 | 2.52171899 |
| 10 | TESK2 | 2.45201926 |
| 11 | VRK2 | 2.30181990 |
| 12 | SMG1 | 2.24698276 |
| 13 | BLK | 2.22708507 |
| 14 | PAK4 | 2.11389809 |
| 15 | MAP3K11 | 2.06770821 |
| 16 | EEF2K | 2.05632582 |
| 17 | WEE1 | 1.95086400 |
| 18 | LRRK2 | 1.91522676 |
| 19 | EPHA2 | 1.88993308 |
| 20 | ARAF | 1.84909417 |
| 21 | MAP3K9 | 1.80129359 |
| 22 | TESK1 | 1.75739960 |
| 23 | NEK2 | 1.75410856 |
| 24 | NEK1 | 1.70403809 |
| 25 | RPS6KA4 | 1.62842066 |
| 26 | PIM2 | 1.56290571 |
| 27 | GRK6 | 1.51129701 |
| 28 | KSR2 | 1.49649074 |
| 29 | MAP4K1 | 1.47104713 |
| 30 | MAPKAPK3 | 1.43390989 |
| 31 | RPS6KB2 | 1.41906507 |
| 32 | MAP3K8 | 1.39442736 |
| 33 | EPHB2 | 1.37808605 |
| 34 | ICK | 1.32223460 |
| 35 | ZAP70 | 1.29754027 |
| 36 | STK10 | 1.23337942 |
| 37 | KDR | 1.23244349 |
| 38 | ALK | 1.15495967 |
| 39 | CDC7 | 1.14278033 |
| 40 | MST1R | 1.14056430 |
| 41 | LATS2 | 1.13084452 |
| 42 | EIF2AK1 | 1.11876077 |
| 43 | MAP2K3 | 1.06917697 |
| 44 | LIMK1 | 1.06363334 |
| 45 | MAP2K2 | 1.03267328 |
| 46 | ILK | 1.01540571 |
| 47 | ERBB4 | 1.00202580 |
| 48 | TLK1 | 0.98146115 |
| 49 | BMX | 0.97732167 |
| 50 | DYRK3 | 0.96974935 |
| 51 | PTK6 | 0.95751493 |
| 52 | LMTK2 | 0.94673482 |
| 53 | RIPK1 | 0.93128838 |
| 54 | MAP3K12 | 0.92861129 |
| 55 | BCKDK | 0.92650395 |
| 56 | TBK1 | 0.91543069 |
| 57 | MOS | 0.90510684 |
| 58 | AURKA | 0.89740280 |
| 59 | PRKG2 | 0.89255534 |
| 60 | PRPF4B | 0.87737795 |
| 61 | TYK2 | 0.86810249 |
| 62 | CDK19 | 0.85545981 |
| 63 | TGFBR2 | 0.84656897 |
| 64 | PAK1 | 0.83646460 |
| 65 | MAP2K7 | 0.83422109 |
| 66 | MET | 0.82446949 |
| 67 | CDK18 | 0.82079921 |
| 68 | TAOK1 | 0.81996516 |
| 69 | SRPK1 | 0.81118627 |
| 70 | RIPK4 | 0.79585489 |
| 71 | MATK | 0.79344362 |
| 72 | TGFBR1 | 0.78899375 |
| 73 | CDK12 | 0.75914456 |
| 74 | BRAF | 0.74402151 |
| 75 | DAPK3 | 0.73261273 |
| 76 | CAMKK1 | 0.71679480 |
| 77 | PLK1 | 0.70471632 |
| 78 | TTK | 0.70021862 |
| 79 | TSSK6 | 0.67395834 |
| 80 | CAMK2G | 0.64693043 |
| 81 | ABL2 | 0.64665297 |
| 82 | SIK2 | 0.63823711 |
| 83 | CSF1R | 0.63672486 |
| 84 | MYLK | 0.63364532 |
| 85 | PTK2 | 0.62428577 |
| 86 | CDK4 | 0.61747235 |
| 87 | PIM1 | 0.60664199 |
| 88 | MINK1 | 0.58238646 |
| 89 | AURKB | 0.57102868 |
| 90 | PAK2 | 0.56702918 |
| 91 | CDK7 | 0.56410271 |
| 92 | CHEK2 | 0.56030388 |
| 93 | RAF1 | 0.54530708 |
| 94 | MARK3 | 0.53971525 |
| 95 | CDK6 | 0.53540700 |
| 96 | KSR1 | 0.52924423 |
| 97 | PRKCI | 0.52633023 |
| 98 | SYK | 0.51544397 |
| 99 | CDK14 | 0.51120642 |
| 100 | STK16 | 0.50534389 |
| 101 | FLT3 | 0.50330997 |
| 102 | DAPK1 | 0.50232379 |
| 103 | PDGFRA | 0.49353971 |
| 104 | CDK9 | 0.48935428 |
| 105 | RPS6KA2 | 0.48142884 |
| 106 | CSNK1G3 | 0.48104498 |
| 107 | PASK | 0.45657366 |
| 108 | FES | 0.44726343 |
| 109 | ROCK2 | 0.43031864 |
| 110 | EIF2AK3 | 0.42720211 |
| 111 | TTN | 0.42702553 |
| 112 | AKT2 | 0.42692118 |
| 113 | SIK1 | 0.39841266 |
| 114 | MAP3K1 | 0.39284916 |
| 115 | TAOK2 | 0.39059286 |
| 116 | NTRK1 | 0.38469977 |
| 117 | BRSK1 | 0.38425887 |
| 118 | CDK11A | 0.38238735 |
| 119 | MAP2K1 | 0.38094246 |
| 120 | MAP3K5 | 0.37956810 |
| 121 | DDR2 | 0.37845177 |
| 122 | PAK6 | 0.36647148 |
| 123 | HCK | 0.36617939 |
| 124 | MAP3K3 | 0.36569793 |
| 125 | CAMKK2 | 0.36166861 |
| 126 | CDK15 | 0.34974994 |
| 127 | BTK | 0.34724160 |
| 128 | EPHB1 | 0.33285447 |
| 129 | EGFR | 0.32405291 |
| 130 | MTOR | 0.32181681 |
| 131 | PRKD3 | 0.32131594 |
| 132 | CAMK2B | 0.30980860 |
| 133 | PDK2 | 0.30261514 |
| 134 | TIE1 | 0.29618231 |
| 135 | PRKD2 | 0.29501549 |
| 136 | CSNK1A1L | 0.28232578 |
| 137 | VRK1 | 0.27877431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.08465280 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.14054769 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.11726695 |
| 4 | Spliceosome_Homo sapiens_hsa03040 | 2.21161309 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.17093768 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.02229592 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.97533252 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 1.91828618 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.90802854 |
| 10 | * Lysosome_Homo sapiens_hsa04142 | 1.88155856 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.86186822 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.83237699 |
| 13 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.82780428 |
| 14 | Shigellosis_Homo sapiens_hsa05131 | 1.70899060 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63723002 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.62901750 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54847293 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54115742 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53988835 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51236215 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47730073 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46784092 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45872322 |
| 24 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.45851777 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.44076478 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.35409904 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34324291 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33809649 |
| 29 | Cell cycle_Homo sapiens_hsa04110 | 1.32181324 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.30659171 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28959840 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24853800 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23827029 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23368762 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.21777892 |
| 36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21052647 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.20638043 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18976597 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.18406350 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15452441 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14589897 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13892881 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.13831008 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13220588 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12597721 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10887819 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10196516 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09927498 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07956904 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07514572 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07263790 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06403633 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04074303 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.04017703 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03499254 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.02916310 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98961712 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98708388 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98232596 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94272618 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94068691 |
| 62 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93227009 |
| 63 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92195518 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89460299 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89347556 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88045500 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87985962 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84688798 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83978745 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83978080 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82360450 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81816171 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80625064 |
| 74 | * Endocytosis_Homo sapiens_hsa04144 | 0.79404445 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78490504 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78416619 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.77487777 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77126221 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.77062224 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76986524 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.76526252 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.75785419 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74834403 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74552598 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.73973392 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73364771 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73168553 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70991596 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70859698 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69268569 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66737150 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65537894 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65024661 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64912175 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63268783 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63017734 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60231526 |
| 98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60087501 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59940683 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59686052 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59224857 |
| 102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58552882 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57062710 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55891517 |
| 105 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55067599 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53777822 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53692276 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51835871 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.51661697 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.50852425 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50007480 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49229053 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.49073475 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48550578 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47973639 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47665988 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46139091 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45872730 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.44841123 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44262361 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43026670 |
| 122 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42674697 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41644898 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40155554 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39586779 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39312808 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38093976 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.37332028 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37156813 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36013926 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34421176 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.30477092 |

